Buprenorphine Tapering: Risks, Research, and Real-Life Stories
So just to summarize, being in treatment less than or Greater Than One Year did not affect the overall rate of re-entry into treatment. So if you tapered longer and slower, you had less re-entry into treatment.
Ever wondered how tapering off buprenorphine might impact the risk of opioid overdose? In this episode of 'Addiction Medicine Journal Club', Dr. John Keenan and Dr. Sonya Del Tredici dive into a critical study that examines the prescribing characteristics associated with opioid overdose following a buprenorphine taper. They break down the nuances of taper duration, timing, and rate, providing valuable insights for both healthcare professionals and those personally affected by addiction. But that's not all.
The episode also explores the accuracy of health records for self-reported nonfatal drug and alcohol overdoses, offering a fresh perspective on data reliability in addiction medicine. Plus, you'll hear about the federal government's initiatives to support pregnant individuals with opioid use disorder, highlighting the importance of specialized care during pregnancy. As a bonus, the hosts touch on Matthew Perry's candid memoir about his journey through addiction and recovery, adding a personal touch to the scientific discussion.
With resources for safer drug use and collaborative efforts to aid primary care physicians, this episode is packed with information that's both practical and inspiring. Tune in for a thoughtful conversation that blends research, real-life stories, and actionable advice.